Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-08-21

FDA Approved: SABRIL — Original Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for Sabril (vigabatrin), marking its initial authorization for infantile spasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SABRIL (VIGABATRIN)

Snippet

ORIG AP for SABRIL (VIGABATRIN)